Your session is about to expire
← Back to Search
Neuromuscular Blocker
Botox for COPD
Phase 2
Waitlist Available
Led By Victoria Do
Research Sponsored by RMW Testing
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Study Summary
This trial tests if Botox injections can improve COPD symptoms in people with moderate COPD.
Who is the study for?
Adults with moderate COPD who can consent and receive back injections, have a specific lung function score (FEV1/FVC < 0.7), experience certain levels of breathlessness, and are not current smokers. Women must test negative for pregnancy and use contraception; men should also use effective contraception.Check my eligibility
What is being tested?
The trial is testing the safety and effectiveness of BOTOX injections to alleviate symptoms in adults with moderate COPD compared to a placebo. Participants will receive subcutaneous injections along their spine.See study design
What are the potential side effects?
Potential side effects may include pain at the injection site, muscle weakness near where the medicine was injected, trouble swallowing or breathing if the medication spreads beyond the injection site, allergic reactions, or flu-like symptoms.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CAT (Average)
Secondary outcome measures
Adverse Reactions
CAT (Change in Units)
COPD Exacerbations
Other outcome measures
6MWT
CAT Score
FEV1
+2 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Treatment ArmActive Control1 Intervention
OnabotulinumtoxinA
Group II: Placebo ArmPlacebo Group1 Intervention
Normal saline
Find a Location
Who is running the clinical trial?
RMW TestingLead Sponsor
Victoria DoPrincipal InvestigatorInvestigator
Share this study with friends
Copy Link
Messenger